chr2-73909088-T-A
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM2PP2PP3_StrongPP5_Very_Strong
The NM_001615.4(ACTG2):c.400T>A(p.Tyr134Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001615.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 Pathogenic:2
- -
The inherited c.400T>A variant has previously been reported as de novo in an individual with prune belly syndrome, MMIHS, and megacystis [PMID:24676022]. The c.400T>A variant is absent in population databases (gnomAD v2.1.1 and v3.1.2, TOPMed Freeze 8, All of US), suggesting it is not a common benign variant in the populations represented in those databases. The c.400T>A variant is located in exon 5 of this 9-exon gene. In silico predictions are in favor of damaging effect for p.(Tyr134Asn) [(CADD v1.6 = 28.6, REVEL = 0.978)]; however, there are no functional studies to support or refute these predictions. The variant is reported in ClinVar [ClinVar ID:132805] as pathogenic in association with Visceral myopathy. Based on available evidence, this inherited c.400T>A, p.Tyr134Asn variant identified in ACTG2 is classified as Likely Pathogenic. -
Visceral myopathy 1 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at